Replies to post #92376 on Biotech Values

[WID]

OT - BIOD: VIAject

I want to know if anyone in here has followed BIOD? The company has been working on two pivotal phase 3 trials for insulin.

Excerpt from the company website:

"It is a proprietary form of regular human insulin which was developed to enable more effective blood-glucose control than currently marketed insulin products. Biodel has submitted a New Drug Application to the FDA for approval to market VIAject® as a treatment for Type 1 and Type 2 diabetes, based upon results from pharmacokinetic, pharmacodynamic and standardized meal studies, two pivotal 6-month Phase 3 clinical trials of VIAject® in patients with Type 1 and Type 2 diabetes, as well as interim results from the long-term, 18-month safety extension trials for patients who completed the pivotal Phase 3 clinical trials."

Thanks a lot for your help.